FDA Approves KRESLADI: First Gene Therapy for Rare, Life-Threatening Childhood Immune Disorder
The FDA has approved KRESLADI, Rocket Pharma’s one-time gene therapy for children with severe LAD-I — a rare, life-threatening immune disorder.
The FDA has approved KRESLADI, Rocket Pharma’s one-time gene therapy for children with severe LAD-I — a rare, life-threatening immune disorder.
BofA upgrades TripAdvisor to Buy and raises price target to $15.
Better Home & Finance partners with Coinbase to let you pledge Bitcoin or USDC as collateral for your down payment — without selling your crypto. Fannie Mae-backed mortgages now make it easier for crypto owners to buy a home.
Unity (U) shares jump 15% in after-hours trading after beating Q1 2026 guidance. Revenue hits $505–508M and Adjusted EBITDA soars 58% YoY.
Pernod Ricard is exploring a potential acquisition of Brown-Forman, the maker of Jack Daniel’s whiskey, amid a tough downturn in the spirits industry. Early talks are ongoing.
Apple is adding Bosch, Cirrus Logic, TDK, and Qnity Electronics to its American Manufacturing Program with a $400 million investment through 2030.